Cryoglobulinemia in hepatitis C virus chronic active hepatitis: effects of interferon-alpha therapy.

We investigated the prevalence of mixed cryoglobulinemia (MC) in 100 cases of chronic hepatitis C virus (HCV) infection and the effect of a 6-month treatment with interferon-alpha (IFN-alpha). Cryoglobulins were detected on admission in 36 of 100 patients and appeared during observation in a further 18 cases. Cryocrit ranged from 0.5% to 20%. Patients with MC were older and had a higher incidence of cirrhosis than those without MC. Immunologic characterization of the cryoprecipitate showed the presence of type II in 84% of cases and type III in 16%. The patients received IFN-alpha (6 MU three times per week) for 6 months. Fifty-seven were responders (i.e., reached normal aminotransferase levels), 26 of these relapsed within 2 months after IFN withdrawal, and 30 did not relapse. After IFN-alpha treatment, cryoglobulinemia disappeared in 11 of the 21 evaluable responders, but in none of the 15 nonresponder patients (p < 0.003). The clearance of MC was associated in all cases with clearance of HCV RNA. The delayed appearance of cryoglobulinemia in responders seems to be associated with a higher probability of relapse.

[1]  M. Shindo,et al.  Hepatic Hepatitis C Virus RNA as a Predictor of a Long-Term Response to Interferon- Therapy , 1995, Annals of Internal Medicine.

[2]  D. Valla,et al.  Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage. , 1994, Gastroenterology.

[3]  H. Joller-jemelka,et al.  Hepatitis C virus and cryoglobulinemia. , 1993, The New England journal of medicine.

[4]  R. Misiani,et al.  Hepatitis C virus and cryoglobulinemia. , 1993, The New England journal of medicine.

[5]  R. Zimmermann,et al.  Interferon alfa in leukocytoclastic vasculitis, mixed cryoglobulinaemia, and chronic hepatitis C , 1993, The Lancet.

[6]  G. Antonelli,et al.  Long-term results of therapy with interferon-alpha for type II essential mixed cryoglobulinemia. , 1991, Blood.

[7]  Phillips Pe,et al.  Hepatitis C virus and mixed cryoglobulinemia. , 1991 .

[8]  G. Pasero,et al.  Association between hepatitis C virus and mixed cryoglobulinemia [see comment]. , 1991, Clinical and experimental rheumatology.

[9]  L. Perrin,et al.  Hepatitis C virus in patients with cryoglobulinemia type II. , 1990, The Journal of infectious diseases.

[10]  Eugene R. Schiff,et al.  Treatment of Chronic Hepatitis C with Recombinant Interferon Alfa , 1989 .

[11]  L. Bonomo,et al.  Treatment of idiopathic mixed cryoglobulinemia with alpha interferon. , 1987, The American journal of medicine.

[12]  Y. Levo,et al.  Liver involvement in the syndrome of mixed cryoglobulinemia. , 1977, Annals of internal medicine.

[13]  J. Clauvel,et al.  Biologic and clinical significance of cryoglobulins. A report of 86 cases. , 1974, The American journal of medicine.

[14]  M. Meltzer,et al.  Cryoglobulinemia--a clinical and laboratory study. II. Cryoglobulins with rheumatoid factor activity. , 1966, The American journal of medicine.

[15]  A. Craxì,et al.  Hepatic Hepatitis C Virus RNA in Chronic Hepatitis C , 1996, Annals of Internal Medicine.

[16]  G. De Sandre,et al.  alpha-Interferon in the treatment of chronic viral hepatitis: effects on fibrogenesis serum markers. , 1993, Journal of Hepatology.

[17]  P. Caramaschi,et al.  Cryoglobulinaemia and hepatitis C virus (HCV) infection. , 1991, Clinical and experimental rheumatology.